• 동의생리병리학회지
• /
• 제20권1호
• /
• pp.181-186
• /
• 2006

A pharmacological inhibition of nitric oxide synthase (NOS) in rats produces vasoconstriction, renal dysfunction, and hypertension. The present study was aimed at investigating whether the methanol extract of Serous commixta cortex (MSC) ameliorates $N^G$-nitro-L-arginine methylester (L-NAME) induced hypertension in rats. Treatment of rats with L-NAME (10 mg/kg/day in drinking water, 5 weeks) caused a sustained increase in systolic blood pressure (SBP). Administration of MSC (100 or 200 mg/kg/day, p.o) significantly lowered the SBP in the L-NAME-treated rats and this effect was maintained throughout the whole experimental period. Moreover, ecNOS expression in aorta and kidney tissue from L-NAME treated rats was significantly restored dy administration of MSC. Furthermore, the impairment of acetylcholine (ACh)-induced relaxation of aortic rings in the L-NAME treated rats was reversed dy administering of MSC. The renal functional parameters including urinary volume, sodium excretion, and creatinine clearance (Ccr) were also restored by administering MSC. Taken together, the present study suggeststhat MSC prevents the increase in SBP in rats with L-NAME-induced hypertension, which may result from the up-regulation of the vascular and renal ecNOS/No system.

• BMB Reports
• /
• 제56권5호
• /
• pp.314-319
• /
• 2023

Sepsis is a life-threatening multi-organ dysfunction with high mortality caused by the body's improper response to microbial infection. No new effective therapy has emerged that can adequately treat patients with sepsis. We previously demonstrated that interferon-β (IFN-β) protects against sepsis via sirtuin 1-(SIRT1)-mediated immunosuppression. Another study also reported its significant protective effect against acute respiratory distress syndrome, a complication of severe sepsis, in human patients. However, the IFN-β effect cannot solely be explained by SIRT1-mediated immunosuppression, since sepsis induces immunosuppression in patients. Here, we show that IFN-β, in combination with nicotinamide riboside (NR), alleviates sepsis by blocking endothelial damage via SIRT1 activation. IFN-β plus NR protected against cecal ligation puncture-(CLP)-induced sepsis in wild-type mice, but not in endothelial cell-specific Sirt1 knockout (EC-Sirt1 KO) mice. IFN-β upregulated SIRT1 protein expression in endothelial cells in a protein synthesis-independent manner. IFN-β plus NR reduced the CLP-induced increase in in vivo endothelial permeability in wild-type, but not EC-Sirt1 KO mice. IFN-β plus NR suppressed lipopolysaccharide-induced up-regulation of heparinase 1, but the effect was abolished by Sirt1 knockdown in endothelial cells. Our results suggest that IFN-β plus NR protects against endothelial damage during sepsis via activation of the SIRT1/heparinase 1 pathway.

• 한국산업보건학회지
• /
• 제23권4호
• /
• pp.384-392
• /
• 2013

Objective: This study inspected incident cases, legal control levels, and GHS(Globally Harmonized System of Classification and Labeling of Chemicals) classification results of strong acids such as hydrogen fluoride, hydrogen chloride, nitric acid, and sulfuric acid, which have been responsible for many recent chemical accidents. As a result, it is deemed necessary for legal control levels of these strong acids to be revised and GHS classification be managed nation-wide. Methods: This study inspected incident cases and legal control levels for strong acids such as hydrogen fluoride, hydrogen chloride, nitric acid, and sulfuric acid. The study analyzed and compared chemical information status and GHS classification results. Results: There were 76 domestic incidents involving strongly acidic hazardous materials over the five years between 2007 and 2011. They include 37 leakage incidents(46.7%) within a workplace, 30 leakage incidents(39.5%) during transportation, and nine leakage incidents(13.8%) following an explosion. The strongly acidic materials in question are defined and controlled as toxic chemicals according to the classes of Substances Requiring Preparation for Accidents, Managed Hazardous Substance, Hazardous Chemical(corrosive) as set forth under the Enforcement Decree of the Toxic Chemicals Control Act and Rules on Occupational Safety and Health Standards of Occupational Safety and Health Act. Among them, nitric acid is solely controlled as a class 6 hazardous material, oxidizing liquid, under the Hazardous Chemicals Control Act. The classification results of the EU ECHA(European Chemicals Agency) CLP(Commission Regulation(EC) No. 790/2009 of 10 August 2009, for the purposes of its adaptation to technical and scientific progress, Regulation(EC) No 1272/2008 of the European Parliament and of the Council on classification, labeling and packaging of substances and mixtures) and NIER (National Institute of Environmental Research) are almost identical for the three chemicals, with the exception of sulfuric acid. Much of the classification information of NITE (National Institute of Technology and Evaluation) and KOSHA(Korea Occupational Safety and Health Agency, KOSHA) is the same. NIER provides 12(41.4%) out of 29 classifications, as does KOSHA.

• 한국토양비료학회지
• /
• 제38권2호
• /
• pp.92-100
• /
• 2005

본 연구는 퇴비원료로 활용할 수 있는 유기성 자원을 선발할 수 있는 선별체계를 확립하고자 여러 지역 및 산업체를 임의로 선정하여 현재의 규정상 퇴비의 원료로 사용 가능한 물질과 사용 불가능한 물질에 해당되는 유기성 오니를 7종 27점 채취하여 일반성분 함량, 중금속 함량, 유기화합물 함량 등을 조사하였고, 오니 추출물을 이용하여 $Microtox^{(R)}$ 분석 및 상추종자 유근신장에 미치는 영향을 조사하였다. 유기물 함량은 모든 오니에서 79.3-98.0%로 퇴비원료에 규정된 60%를 크게 상회하였고, 전질소 함량은 0.8-2.6% 범위이었다. 철과 알루미늄 함량은 상당히 높았으며, 퇴비원료의 규제기준인 중금속 8종의 경우 아연과 구리함량은 섬유오니에서, 크롬함량은 섬유 및 피혁오니에서, 니켈함량은 섬유, 피혁, 식품, 하수오니 4 (공단지역)에서 그리고 수은함량은 하수오니 3 및 4 (대도시, 공단지역)에서 규제기준치 이상으로 조사되었다. 납, 비소, 카드뮴의 함량은 모든 시료에서 규제 기준치보다 낮았다. HEM 함량은 섬유오니에서 다른 재료보다 월등히 높았으며, PAHs 함량은 제지 오니에서 가장 높았고 그 다음은 피혁오니>하수오니 2 (중소도시)>하수오니 4 (공단지역) 순으로 낮았다. PAHs 함량은 anthracene, phenanthrene, naphthalene, acenaphthene 및 fluorene가 다른 화합물 함량보다 상당히 높았으며, 이들 화합물 함량에서는 제지오니, 피혁오니, 하수오니 2 4 1 (중소도시, 공단지역, 읍 면단위 농어촌지역)에서 다른 오니보다 높았다. $Microtox^{(R)}$ 분석에서 가축분뇨 (돈분뇨), 음식물류 폐기물, 하수오니 1 (읍 면단위 농어촌지역), 식품오니에서 $EC_{50}$ 값이 비교적 높게 나타났으나, 피혁오니, 섬유오니, 하수오니 4 (공단지역)에서 가장 낮은 수치를 보였다. 제지오니, 하수오니 3 (대도시), 식품오니, 피혁오니의 추출물은 상추종자의 유근 신장율을 크게 저해하였다. 따라서 현재 퇴비원료 규제기준인 유기물과 중금속 함량 (8성분) 이외 추가로 일반성분, 미량 중금속, 유해 유기화합물, 생물검정법 및 포장비효시험 등을 이용하여 유망한 유기성 오니의 퇴비원료로 활용 가능성을 검토할 수 있는 방법으로 선별체계를 구축한다면 현재 퇴비원료의 규제기준을 보완할 수 있으며 최종적으로 가장 효과적이고 확실한 검정방법인 작물재배시험을 실시하기 이전에 유용한 유기성 자원의 활용여부를 판별해 낼 수 있으리라 생각된다.

• 한국환경보건학회지
• /
• 제30권3호
• /
• pp.185-190
• /
• 2004

Acute aquatic toxicity of effluents discharged from five dyeing plants in Gyeong-gi province were evaluated to assess whether the current Korean water quality standards(KWQS) could protect aquatic life. Chemical analyses of all parameters regulated under KWQS, except for E-coli, were also carried out to determine regulation compliance of the samples. All the effluent samples were satisfied with KWQS except for the color in only one sample. In acute Daphnia magna toxicity tests, significant mortality was observed in one of five samples and EC50 was 12.1%(95% confidence interval 9.1-16.2), which was in compliance with KWQS. The result of the Microtox assay indicated that acute microbial toxicity existed in effluents from three out of five plants, two of which were in compliance with KWQS. The agreement between regulation compliance of chemical concentrations of effluent and observed toxicity from various biological toxicity tests was very poor to fair (kappa = 0.194~0.250). The data presented suggest that exposure to dyeing wastewater which were in compliance with Korean water quality standards may not be safe to aquatic biota, and multiple tropical levels should be considered in aquatic toxicity monitoring of dyeing industry.

• 한국지반공학회:학술대회논문집
• /
• 한국지반공학회 2008년도 추계 학술발표회
• /
• pp.1463-1474
• /
• 2008

In order to investigate stabilization effect and sustainability on As-contaminated farmland soils which were affected the abandoned mine site and stabilized by zerovalent iron(ZVI) and industrial by-products, batch-scale and pilot-scale tests were carried out. In batch tests, ZVI and industrial by-products(blast furnace slag, steel refining slag and oyster shell powder) were used in treatment materials to reduce the As leaching. Industrial by-products were mixed with As-contaminated soils, in the ratio of 1%, 3%, 5% and 7% on the weight base of dried soil. The results of batch-scale tests was shown that the reduction of As concentration was observed in all samples and it was expected that ZVI and steel refining slag were more effective than other treatment materials to stabilize As compounds. In pilot-scale tests, columns were filled with untreated soils and treated soils mixed with ZVI and steel refining slag in the same mixing ratio of 3%. Distilled water was discharged into the columns with the velocity of 0.3 pore volume/day. During the test, pH, EC, Eh and As concentration were measured in the regular term(1pore volume). after six months, pilot-scale tests were retested to investigate sustainability of treatment materials. As a result, It was shown that the leachate from control column was continuously released during the test period and its concentration was greater than $100ug{\cdot}L^{-1}$ which was exceeded the national regulation of water discharged to river or stream ($50ug{\cdot}L^{-1}$). On the other hand, soil treated with ZVI and steel refining slag showed that the concentrations of leachate were lower than national regulation of water discharged to river or stream. Therefore it was expected that ZVI and steel refining slag could be applied to the farmland site as the alternative treatment materials.

• 동의생리병리학회지
• /
• 제18권1호
• /
• pp.84-92
• /
• 2004

The present study examined the effects of Taekunyukmijiwhang-tang (TV) on blood pressure and renal function in nitric oxide (NO)-dependent hypertensive rats. A phamacological inhibition of nitric oxide synthase (NOS) for 4-6 weeks produces renal vasoconstriction, renal dysfunction, and progressive severe hypertension. Treatment of rats with NG-Nitro-L-arginie methylester (L-NAME) (100 mg/L, 6 weeks), which is a nonspecific NOS inhibitor, cause a sustained increase in systolic blood pressure (SBP), along with the decrease in expression of ecNOS in the kidney and thoracic aorta. The expression of Na, K-ATPase α1 subunit in the kidney was also reduced in the L-NAME induced hypertensive rats group. The renal functional parameters including urine osmolality (Uosm), creatinine clearance (Ccr), which is an index of glomerular filtration (GFR) were decreased in rat with L-NAME induced hypertension. while solute-free water reabsoption (TcH₂O) was unchanged in all experimental group. However, the group combined treated with TV and L-NAME did not develop hypertension and expression of ecNOS in the aorta was restored. The expression of Na/sup +/, K/sup +/-ATpase α1 subunit in the kidney was markedly restored in L-NAME-induced hypertension rats by administration of TV along with the restoration of urinary volume (UV) and sodium excretion (UNaV), whlie Na/sup +/, K/sup +/-ATPase /β1 subunit was not altered. These results suggest that TV attenuates an increase in SSP in the L-NAME induced hypertension and restores partially renal function, which seems to be caused by up-regulation of expression of Na/sup +/, K/sup +/-ATPase α1 subunit in the kidney and ecNOS in thoracic aorta.

• Journal of Pharmaceutical Investigation
• /
• 제36권6호
• /
• pp.421-435
• /
• 2006

The objective of this report is to introduce the European Union's variation rules governing medicinal products that are subject to post-approval changes. The EMEA outlines a variety of changes occurring to approved medicinal products. It also recommends a marketing authorisation holder to follow specific post-approval applications in various situations. For instance, the Commission Regulation(EC) No. 1085/2003 explains variation types and suggests post-authorisation procedures with which an applicant should comply. In all cases of minor and major variations the applicant has to investigate and validate whether or not the intended changes would have impact on the safety, efficacy and quality of a drug product. The applicant should then submit to the EMEA a variation application with adequate documentation in support of the notified changes. This procedure is implemented to ensure that changes to the approved medicinal product do not cause my public health concerns. In fact, the post-authorisation guidance categorizes post-approval changes into type IA/IB variations, type II variations, and extension applications. Such classifications determine administrative procedures to be followed in an efficient manner. Based on the type of a variation, the regulatory agency opts to reduce or extend the evaluation time-frame. The thrust of the EU's post-authorisation guidance is introduced in text with appropriate explanation. All these information will be likely to be helpful in updating a Korean regulatory guidance that could better deal with post-approval changes to generic drugs available in the market.

• Molecules and Cells
• /
• 제26권3호
• /
• pp.265-269
• /
• 2008

Calumenin, a multiple EF-hand $Ca^{2+}$ binding protein is located in the SR of mammalian heart, but the functional role of the protein in the heart is unknown. In the present study, an adenovirus gene transfer system was employed for neonatal rat heart to examine the effects of calumenin over-expression (Calu-OE) on $Ca^{2+}$ transients. Calu-OE (8 folds) did not alter the expression levels of DHPR, RyR2, NCX, SERCA2, CSQ and PLN. However, Calu-OE affected several parameters of $Ca^{2+}$ transients. Among them, prolongation of time to 50% baseline ($T_{50}$) was the most outstanding change in electrically-evoked $Ca^{2+}$ transients. The higher $T_{50}$ was due to an inhibition of SERCA2-mediated $Ca^{2+}$ uptake into SR, as tested by oxalate-supported $Ca^{2+}$ uptake. Furthermore, co-IP study showed a direct interaction between calumenin and SERCA2. Taken together, calumenin in the cardiac SR may play an important role in the regulation of $Ca^{2+}$ uptake during the EC coupling process.

• 항공우주정책ㆍ법학회지
• /
• 제26권1호
• /
• pp.127-145
• /
• 2011

European Union unilaterally included the emissions from aviation activities into EU ETS on 19 November 2008 by amending Directive 2003/87/EC. According to the Directive all the emissions(mainly against the CO2) from aviation activities shall be subject to the regulation of EU ETS from 2012. For the period from 1 January 2012 to 31 December 2012, the total quantity of allowances to be allocated to aircraft operators shall be equivalent to 97% of the historical aviation emission s. From 1 January 2013, the allowances will be reduced to 95%. The allocation of allowances which may be applied by each operator with free of charge will be reduced from 85% to 82% from 1 January 2012 to 1 January 2013. Since the Directive will affect every country's airline industry more or less, the nations and international organizations respond variously. The controversial focus is that whether EU has the right to unilaterally include the emissions from international aviation activities into EU ETS. This article firstly analyzes the effect caused by EU ETS to China's airline industry, and then studies the legality of the action of EU subject to current positive international law, and finally draws the conclusion that EU enjoys no such right to unilaterally include the emissions from international aviation activities.